John Roback to Female
This is a "connection" page, showing publications John Roback has written about Female.
Connection Strength
0.044
-
Current Evidence for the Use of Prophylactic Transfusion to Treat Sickle Cell Disease During Pregnancy. Transfus Med Rev. 2018 10; 32(4):220-224.
Score: 0.010
-
Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma. Transfusion. 2021 06; 61(6):1740-1748.
Score: 0.003
-
One-Stop Serum Assay Identifies COVID-19 Disease Severity and Vaccination Responses. Immunohorizons. 2021 05 17; 5(5):322-335.
Score: 0.003
-
Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System. Ann Intern Med. 2021 05; 174(5):649-654.
Score: 0.003
-
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease. Blood Adv. 2020 09 22; 4(18):4278-4281.
Score: 0.003
-
Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020. Emerg Infect Dis. 2020 12; 26(12):2974-2978.
Score: 0.003
-
Anemia induces gut inflammation and injury in an animal model of preterm infants. Transfusion. 2019 04; 59(4):1233-1245.
Score: 0.003
-
Enteral iron supplementation, red blood cell transfusion, and risk of bronchopulmonary dysplasia in very-low-birth-weight infants. Transfusion. 2019 05; 59(5):1675-1682.
Score: 0.003
-
Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease. Transfusion. 2019 02; 59(2):448-453.
Score: 0.003
-
Stability of anti-A blood group titers among blood group B renal transplant candidates. Transfusion. 2018 12; 58(12):2747-2751.
Score: 0.003
-
Trends in transfusion rates after the FOCUS trial. J Comp Eff Res. 2018 02; 7(2):113-120.
Score: 0.003
-
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 05; 24(5):973-982.
Score: 0.002
-
Daratumumab (anti-CD38) induces loss of CD38 on red blood cells. Blood. 2017 06 01; 129(22):3033-3037.
Score: 0.002